Miguel Peña-Rico

3PUBLICATIONS

13CO-AUTHORS

Molecular targetsIndustrial molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Feb 13, 2026

AX-2: A Promising Non-Hemolytic Protein of Bacillus thuringiensis with Potent Selective Cytotoxicity Against Breast Cancer Cells.

Alain Cruz-Nolasco, Miguel Angel Peña-Rico, Sibel J Estrada-Escobedo

|Nov 19, 2021

Addition of proteinase K during the culture alter the physiology of Bacillus thuringiensis culture and the cry1Ac, nprX, nprA, and spo0A gene transcription.

Miguel A Peña-Rico, Humberto R Bravo-D, Crisanto Roldan-Sabino

|Aug 06, 2021

Parasporin A13-2 of Bacillus thuringiensis Isolates from the Papaloapan Region (Mexico) Induce a Cytotoxic Effect by Late Apoptosis against Breast Cancer Cells.

Diego Becker Borin, Karen Castrejón-Arroyo, Alain Cruz-Nolasco

Pageof 1

Frequent Collaborators

3 joint publications

A Karin Navarro-Mtz

2 joint publications

Luz Camacho

1 joint publications

Karla V Castro-Cerritos

1 joint publications

Ariana Huerta-Heredia

1 joint publications

Alain Cruz-Nolasco

1 joint publications

Erick A Juarez-Arellano

1 joint publications

Genaro Vázquez-Victorio

1 joint publications

Angelica S Martinez-Ramirez

1 joint publications

Michele Rorato Sagrillo

1 joint publications

Roberto C Vianna Santos

Frequent Collaborators

3 joint publications

A Karin Navarro-Mtz

2 joint publications

Luz Camacho

1 joint publications

Karla V Castro-Cerritos

1 joint publications

Ariana Huerta-Heredia